Date |
Time |
Source |
Heading |
1/08/2024 | 07:00 | EDGAR2 | Form 15-12G - Securities registration termination [Section.. |
1/03/2024 | 00:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
12/27/2023 | 17:41 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:40 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:36 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 17:35 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/27/2023 | 09:44 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
12/27/2023 | 09:43 | EDGAR2 | Form POS AM - Post-Effective amendments for registration.. |
12/27/2023 | 09:42 | EDGAR2 | Form S-8 POS - Securities to be offered to employees in.. |
12/27/2023 | 08:54 | EDGAR2 | Form 8-K - Current report |
12/27/2023 | 08:31 | PRNUS | Lilly Completes Acquisition of POINT Biopharma |
12/18/2023 | 08:14 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
12/18/2023 | 07:30 | GLOBE | Lantheus and POINT Biopharma Announce Positive Topline.. |
12/18/2023 | 06:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
12/05/2023 | 06:25 | IHMARKETNEWS | Moody’s Reassesses China, GitLab Exceeds Estimates, Twilio.. |
12/04/2023 | 07:22 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
12/04/2023 | 06:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
11/17/2023 | 07:05 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
11/17/2023 | 06:45 | PRNUS | Lilly Extends Tender Offer to Acquire POINT Biopharma to.. |
11/15/2023 | 07:00 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
11/14/2023 | 16:33 | PRNUS | Lilly Announces the Receipt of NRC Consent in Connection.. |
11/13/2023 | 07:30 | GLOBE | POINT Biopharma Reports Third Quarter 2023 Financial Results.. |
11/13/2023 | 07:15 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/08/2023 | 17:28 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
11/08/2023 | 16:56 | PRNUS | Lilly Announces Extension of Tender Offer to Acquire POINT.. |
11/07/2023 | 18:33 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/02/2023 | 18:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
11/01/2023 | 16:40 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
10/27/2023 | 16:20 | EDGAR2 | Form SC 14D9/A - Solicitation, recommendation statements:.. |
10/13/2023 | 07:11 | EDGAR2 | Form SC 14D9 - Solicitation, recommendation statements |
10/03/2023 | 17:24 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
10/03/2023 | 10:03 | IHMARKETNEWS | Keep An Eye Out: Pre-Market Movers And Recommendations |
10/03/2023 | 07:37 | EDGAR2 | Form SC14D9C - Written communication relating to third party.. |
10/03/2023 | 07:35 | EDGAR2 | Form 8-K - Current report |
10/03/2023 | 06:45 | PRNUS | Lilly to Acquire POINT Biopharma to Expand Oncology.. |
9/18/2023 | 08:00 | GLOBE | POINT Biopharma and Athebio Announce Partnership to Develop.. |
8/14/2023 | 10:22 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
8/14/2023 | 07:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/14/2023 | 07:30 | GLOBE | POINT Biopharma Reports Second Quarter 2023 Financial.. |
8/14/2023 | 07:21 | EDGAR2 | Form 8-K - Current report |
8/03/2023 | 16:05 | EDGAR2 | Form 8-K - Current report |
7/31/2023 | 09:00 | GLOBE | ITM and POINT Biopharma Expand Global Supply Agreement for.. |
6/26/2023 | 07:45 | GLOBE | POINT Biopharma and AdvanCell to Collaborate in the.. |
6/26/2023 | 07:30 | GLOBE | POINT Biopharma Expands Its Research with Next-Generation.. |
6/12/2023 | 08:00 | GLOBE | POINT Biopharma Announces Appointment of Dr. Bridget Martell.. |
6/07/2023 | 07:00 | GLOBE | POINT Biopharma to Host Virtual Investor Day on Tuesday,.. |